Status: current, Defined. Date: 31-Jan 2013. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 408661000036119 | Topotecan (Agila) (topotecan 4 mg) powder for injection, 1 x 4 mg vial (trade product pack) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 408671000036110 | Topotecan (Agila) 4 mg powder for injection, 1 vial | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Topotecan (Agila) 4 mg powder for injection, 1 vial | Is a | trade product pack | true | Inferred relationship | Some | ||
| Topotecan (Agila) 4 mg powder for injection, 1 vial | Is a | topotecan 4 mg injection, 1 vial | true | Inferred relationship | Some | ||
| Topotecan (Agila) 4 mg powder for injection, 1 vial | has TPUU | Topotecan (Agila) 4 mg powder for injection, 4 mg vial | true | Inferred relationship | Some | 1 | |
| Topotecan (Agila) 4 mg powder for injection, 1 vial | has TP | Topotecan (Agila) | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Topotecan (Agila) 4 mg powder for injection, 1 vial | Is a | True | Topotecan (Agila) 4 mg powder for injection, 1 vial | Inferred relationship | Some |
Reference Sets
Trade product pack reference set
FHIR